»çÀÌÅäÄ«ÀÎ ½ÃÀå : À¯Çüº°, Ä¡·á ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Cytokine Market, By Type, By Therapeutic Application, By End User, By Geography
»óǰÄÚµå : 1673038
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,640,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,772,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀåÀº 2025³â¿¡ 988¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 1,785¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 8.8%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 988¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 8.80% 2032³â °¡Ä¡ ¿¹Ãø 1,785¾ï ´Þ·¯
±×¸². 2025³â Áö¿ªº° »çÀÌÅäÄ«ÀÎ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°
Cytokine Market-IMG1

»çÀÌÅäÄ«ÀÎÀº ¸é¿ª¹ÝÀÀ°ú ¿°Áõ¹ÝÀÀÀ» Á¦¾îÇϰí Á¶ÀýÇÏ´Â µ¥ Áß¿äÇÑ ¼¼Æ÷ ½ÅÈ£Àü´Þ ´Ü¹éÁúÀÔ´Ï´Ù. »çÀÌÅäÄ«ÀÎÀº ¸é¿ª¼¼Æ÷ °£ÀÇ °¡±³¿ªÇÒÀ» Çϸç, ¸é¿ª¹ÝÀÀÀÇ ÀϺηΠ¸é¿ª°ú ¿°ÁõÀ» ¸Å°³Çϰųª Á¶ÀýÇÕ´Ï´Ù. ¸¸¼º ¿°Áõ¼º Áúȯ, ¾Ï, °¨¿°¼º Áúȯ Áõ°¡¿Í ÇÔ²² Áø´Ü ¸ñÀûÀÇ »çÀÌÅäÄ«ÀÎ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ DNA ±â¼úÀÇ ¹ßÀüÀ¸·Î ´Ù¾çÇÑ À¯ÇüÀÇ »çÀÌÅäÄ«ÀÎÀ» ´ë·® »ý»êÇÒ ¼ö ÀÖ°Ô µÇ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª »çÀÌÅäÄ«ÀÎ ¿¬±¸¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå È®´ë°¡ ¾î´À Á¤µµ ¾ïÁ¦µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¸¸¼º Áúȯ ¹× »ý¸íÀ» À§ÇùÇÏ´Â Áúº´ÀÇ ¹ßº´·ü Áõ°¡´Â »çÀÌÅäÄ«ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â Àü ¼¼°è ¾Ï°ú °¨¿°¼º Áúȯ Áõ°¡¸¦ µé ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°è ¾Ï ȯÀÚ ¼ö´Â 1,930¸¸ ¸í¿¡ ´ÞÇϸç, 2020³â¿¡´Â 1,000¸¸ ¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¶Âù°¡Áö·Î Äڷγª19, °áÇÙ°ú °°Àº °¨¿°¼º ÁúȯÀº »çÀÌÅäÄ«ÀÎ ÇÁ·ÎÆÄÀϸµÀ» Æ÷ÇÔÇÑ »õ·Î¿î Áø´Ü ¹× Ä¡·á Á¢±Ù¹ýÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »çÀÌÅäÄ«ÀÎ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ¹× ¹Î°£ ±â°üÀÇ ÀÚ±Ý Áö¿øÀ» ´Ã¸®±â À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª »çÀÌÅäÄ«ÀÎ »ý»ê ±â¼úÀÇ ³ôÀº »ý»ê ºñ¿ë°ú ±â¼úÀû ÇѰè·Î ÀÎÇØ ½ÃÀå ÀáÀç·ÂÀÌ °è¼Ó ÀúÇØµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »çÀÌÅäÄ«ÀÎÀÇ ÂªÀº À¯Åë±âÇѰú ³·Àº ¾ÈÁ¤¼ºÀº º¸´Ù ±¤¹üÀ§ÇÑ »ó¾÷È­¿¡ ´ëÇÑ µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ »çÀÌÅäÄ«ÀÎ(Cytokine) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ¿¹ÃøÇÑ º¸°í¼­ÀÔ´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀ» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott, AB Sciex, Agilent Technologies Inc, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd. Quest Diagnostics Inc., Danaher, DiaSorin S.p.A., Immunodiagnostic Systems, Fujirebio, Inc. µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è »çÀÌÅäÄ«ÀÎ ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, À¯Çüº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦5Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, Ä¡·á ¿ëµµº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦6Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦7Àå »çÀÌÅäÄ«ÀÎ ½ÃÀå, Áö¿ªº°, 2020³â-2032³â, ±Ý¾×(10¾ï ´Þ·¯)

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cytokine Market is estimated to be valued at USD 98.84 Bn in 2025 and is expected to reach USD 178.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 98.84 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.80% 2032 Value Projection: USD 178.50 Bn
Figure. Cytokine Market Share (%), By Region 2025
Cytokine Market - IMG1

Cytokines are cell-signalling proteins that are crucial for controlling and regulating immune responses and inflammatory reactions. They act as the bridge intermediaries between immune cells and mediate or regulate immunity and inflammation as part of immune response. With the increasing prevalence of chronic inflammatory diseases, cancer, and infectious diseases, the demand for cytokine assays for diagnostic purposes has been growing significantly. Advancements in recombinant DNA technology have enabled mass production of different types of cytokines, thus aiding market growth. However, high costs associated with cytokine research may restrain market expansion to some extent over the forecast period.

Market Dynamics:

Increasing incidence of chronic and life-threatening diseases is a key factor driving the cytokine market growth. Some of the major market drivers include rising cases of cancers and infectious diseases globally. , the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Similarly, infectious diseases like COVID-19, tuberculosis, etc. have surged the need for new diagnostic and therapeutic approaches including cytokine profiling. Further, initiatives by governments and private organizations to increase funding for cytokine research present lucrative opportunities for market players. However, high production costs and technical limitations of cytokine production techniques continue to hamper market potential. Short shelf-life and poor stability of cytokines also challenge wider commercialization.

Key Features of the Study:

This report provides in-depth analysis of the global cytokine market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cytokine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, DiaSorin S.p.A, Immunodiagnostic Systems, Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Cytokine Market, By Type, 2020-2032, (USD Bn)

5. Cytokine Market, By Therapeutic Application, 2020-2032, (USD Bn)

6. Cytokine Market, By End User, 2020-2032, (USD Bn)

7. Cytokine Market, By Region, 2020 - 2032, Value (USD Bn)

8. Competitive Landscape

9. Analyst Recommendations

10. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â